Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-17
A preclinical study links ENO1-associated glycolysis in infarct macrophages to inflammatory signaling and evaluates an acid-responsive siRNA nanocarrier. The integrated data support an ENO1–lactate–KLF4 model and report changes in cardiac injury and function in mice, while translation to humans and longer-term safety remain unresolved.
ENO1 and Metabolic Control of Cardiac Repair
2026-11-17
A preclinical study examines whether ENO1 links macrophage glycolysis to inflammatory remodeling after myocardial infarction and whether an acid-responsive nanocarrier can test that mechanism. The reported results connect ENO1 silencing with altered macrophage metabolism, reduced inflammatory features, and improved structural and functional measures in mice, while leaving important questions about mechanism, translation, and long-term safety.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-16
A preclinical study links ENO1 activity in infarct-associated macrophages with glycolytic remodeling and inflammatory polarization, then evaluates an acid-responsive nanocarrier for targeted siRNA delivery. The findings support a mechanistic model involving lactate and KLF4, while leaving important questions about pathway specificity, long-term safety, and translation beyond murine myocardial infarction.
Annexin V-PE and Postinfarction Repair
2026-11-16
Annexin V-PE fluorescence occupies a downstream measurement position in research on ENO1-driven macrophage dysfunction after myocardial infarction. The assay reports cell-surface phosphatidylserine exposure, while the broader evidence for mechanism comes from transcriptomics, metabolic measurements, genetic perturbation, rescue experiments, tissue remodeling, and cardiac function.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-15
A preclinical study examines ENO1 as a metabolic regulator of post-infarction macrophage behavior and evaluates an acid-responsive nanocarrier for cell-directed siRNA delivery. The findings connect ENO1 silencing with altered glycolysis, lactate signaling, inflammatory polarization, and reported structural and functional outcomes in a murine myocardial-infarction model.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-14
A preclinical study examines how ENO1-linked metabolic remodeling shapes macrophage behavior after myocardial infarction and evaluates an acid-responsive siRNA nanocarrier as a mechanistic research tool.
SCP4, H3T3 and Chromosome Stability
2026-11-13
A mechanistic study positions SCP4 as a chromatin-associated phosphatase that directly removes the mitotic H3T3 phosphate. Its cellular and embryonic findings connect disrupted SCP4 activity with altered chromosomal passenger complex behavior, chromosome-segregation errors and aneuploidy, while leaving important model and replication boundaries.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-13
A preclinical study tests whether ENO1 links glycolytic remodeling in infarct-associated macrophages to inflammatory polarization and whether acid-responsive siRNA delivery can interrogate that relationship. The findings connect ENO1 silencing with reduced glycolytic activity, altered lactate–KLF4 signaling, macrophage-enriched delivery, and favorable tissue and functional readouts in mice. Interpretation remains limited to the tested models and endpoints.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-12
A preclinical study examines whether ENO1 links glycolytic remodeling to inflammatory macrophage behavior after myocardial infarction and tests an acid-responsive nanocarrier for siRNA delivery. The reported findings connect ENO1 silencing with altered lactate–KLF4 signaling, macrophage targeting, and changes in cardiac injury and repair readouts.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-12
A preclinical study examines whether ENO1 links post-infarction macrophage metabolism to inflammatory polarization and whether an acid-responsive nanocarrier can test that mechanism in cellular and murine models.
When Apoptosis Results Change Meaning
2026-11-11
Annexin V fluorescence is a context-dependent readout of accessible cell-surface phosphatidylserine, not a standalone explanation of cell death. In postinfarction research, its meaning depends on the cell population, comparator, disease phase, and how the signal fits with metabolic, inflammatory, histological, and functional evidence.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-11
A preclinical study examines whether ENO1 links inflammatory macrophage metabolism to post-infarction tissue injury and whether an acid-responsive nanocarrier can test that mechanism through targeted siRNA delivery. The reported findings connect ENO1 silencing with altered glycolysis, lactate–KLF4 signaling, reduced inflammatory features, and improved structural outcomes in a murine infarction model, while leaving important translational and mechanistic questions open.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-10
A preclinical study links ENO1-dependent glycolytic remodeling in infarct-associated macrophages with inflammatory polarization and evaluates an acid-responsive siRNA nanocarrier as a mechanistic intervention. The findings connect altered lactate signaling, KLF4, macrophage state, and post-infarction tissue outcomes, while remaining bounded by animal-model and short-term safety evidence.
ENO1, Macrophages, and Cardiac Repair
2026-11-10
A preclinical study examines ENO1 as a metabolic regulator of postinfarction macrophage behavior and evaluates an acid-responsive siRNA nanocarrier as a mechanistic research tool. The findings connect glycolytic remodeling, lactate-associated signaling, inflammatory polarization, and cardiac tissue outcomes in murine models.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-09
A preclinical study examines whether ENO1 links post-infarction macrophage metabolism to inflammatory polarization and whether an acid-responsive nanocarrier can test that mechanism in vivo. The findings support an ENO1–glycolysis–lactate–KLF4 pathway associated with inflammatory macrophage behavior and cardiac remodeling, while remaining bounded by murine models and selected safety assessments.